Detail
| RLID: | RLID00028005 |
| RNA Symbol: | hsa-let-7c-5p |
| RNA Category: | miRNA |
| Organism: | Homo sapiens |
| Subcellular Localization: | |
| Localization | Tissue | Validated Method | PMID |
| Cytoplasm | HeLa cell | Microarray | 21695135 |
| Description: While 44 miRNAs showed a greater enrichment in the cytosolic Hy3-labeled RNA fraction, 13 miRNAs were significantly and reproducibly enriched in the mitochondrial Hy5-labeled RNA sample (ranging from 1.5- to 56-fold), namely hsa-miR-1973, hsa-miR-1275, hsa-miR-494, hsa-miR-513a-5p, hsa-miR-1246, hsa-miR-328, hsa-miR-1908, hsa-miR-1972, hsa-miR-1974, hsa-miR-1977, hsa-miR-638, hsa-miR-1978 and hsa-miR-1201 (Figure 5A). Data are collected from Figure 5. | |||
Other Subcellular Localization:
| RLID | Localization | Tissue | Validated Method | PMID |
| RLID00027998 | Circulating | Serum | qRT-PCR | 21098710 |
| RLID00027999 | Circulating | Blood | qRT-PCR|Microarray | 23424776 |
| RLID00028000 | Circulating | Cerebrospinal fluid | Next-generation sequencing|RT-PCR | 23525801 |
| RLID00028001 | Circulating | Serum | Next-generation sequencing|RT-PCR | 23525801 |
| RLID00028002 | Circulating | Serum | Next-generation sequencing | 23641832 |
| RLID00028003 | Circulating | Serum | Next-generation sequencing | 25359176 |
| RLID00028004 | Cytoplasm | Nasopharyngeal carcinoma cell | Next-generation sequencing | 20498841 |
| RLID00028006 | Extracellular vesicle | HEK293T|HMEC-1|Mononuclear cell | Next-generation sequencing | 22849433 |
| RLID00028007 | Exosome | Serum | Microarray | 18589210 |
| RLID00028008 | Exosome | Saliva | Microarray | 19627513 |
| RLID00028009 | Exosome | Breast cancer cell | Microarray | 20976003 |
| RLID00028010 | Exosome | Dendritic cell | Microarray | 21505438 |
| RLID00028011 | Exosome | B cell | Microarray | 21505438 |
| RLID00028012 | Exosome | Breast milk | Next-generation sequencing | 22211110 |
| RLID00028013 | Exosome | Malignant melanoma cell | Microarray | 23056502 |
| RLID00028014 | Exosome | Brain tissue | Microarray | 23382797 |
| RLID00028015 | Exosome | Plasma | Next-generation sequencing | 23663360 |
| RLID00028016 | Exosome | Esophageal cancer cell | Next-generation sequencing | 25184951 |
| RLID00028017 | Microvesicle | Plasma | Next-generation sequencing | 23077538 |
| RLID00028018 | Microvesicle | Seminal Plasma | Microarray | 23539611 |
| RLID00028019 | Microvesicle | Follicular fluid | Microarray | 23666971 |
| RLID00028020 | Mitochondrion | Skeletal muscular cell | In situ hybridization|qRT-PCR | 21637849 |
| RLID00028021 | Mitochondrion | HeLa cell | Next-generation sequencing | 22984580 |
| RLID00028022 | Mitochondrion | Eembryonic kidney cell | Next-generation sequencing | 22984580 |
| RLID00028023 | Nucleus | Nasopharyngeal carcinoma cell | Next-generation sequencing | 20498841 |
| RLID00028024 | Nucleus | Colon adenocarcinoma cell | Microarray | 20864815 |
| RLID00028025 | Nucleus | HeLa cell | Next-generation sequencing | 22058130 |
| RLID00028026 | Mitochondrion | Myoblast | In situ hybridization|qRT-PCR | 21637849 |
| RLID00028027 | Exosome | Gastric cancer cell | - | 22529849 |
| RLID00028028 | Exosome | Renal carcinomas cell | - | 22529849 |
| RLID00028029 | Circulating | Serum | Next-generation sequencing | 22719975 |